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Several classes of drugs are currently available for the treatment of helminthiasis 
in humans and animals, the so-called anthelmintics. Most of these drugs are administered 
by the oral route, where absorption into the systemic circulation occurs through 
the intestinal barrier. However, the course and extent of this absorption may be limited 
by biotransforming enzymes and transport proteins, in particular the family of so-called 
ATP-binding cassette transporters. These transporters are capable of returning many 
xenobiotics, including many drugs, back into the lumen of the gut and are the first line 
of defence against the entry of these substances into the body. An important 
representative of this group of transporters is P-glycoprotein, which is known for its broad 
substrate specificity. On this transporter, drugs can act as substrates but also as inhibitors 
and/or inducers, which may lead to the risk of drug-drug interactions.  
There is relatively little information about the effect of anthelmintics 
on P-glycoprotein inhibition. The most studied anthelmintic in the context 
of P-glycoprotein is ivermectin, from the group of macrocyclic lactones, which has been 
considered for many years as a proven inhibitor of this efflux transporter.  
The aim of this thesis was to investigate whether and to what extent other 
anthelmintics inhibit P-glycoprotein function in the intestinal barrier. For this purpose, 
we used the ex vivo method of precision-cut intestinal slices prepared from the rat ileum. 
Rhodamine 123 was used as a model substrate and CP-100356 as a specific inhibitor. 
We tested anthelmintics from different classes at concentrations of 1 and/or 10 µM 
and their ability to increase rhodamine 123 accumulation in intestinal tissue. In addition, 
concentration-dependence tests on rhodamine 123 accumulation were performed for three 
selected drugs (ivermectin, closantel and niclosamide). 
 
 
A number of agents showed statistically significant increases in relative 
rhodamine 123 accumulation, namely ivermectin, moxidectin, oxyclosanide, rafoxanide, 
niclosamide, monepantel and praziquantel, all at a concentration of 10 µM. 
Doramectin then showed a significant increase in accumulation at both 1 and 10 µM. 
No inhibitory effect was observed with benzimidazole anthelmintics at a concentration 
of 10 µM.  
